SELDA ÇELİK, MERAL KELLECİ, İLHAN SATMAN

Bazal-Bolus İnsülin Tedavisi Kullanan Tip 2 Diyabetlilerin Kan Şekeri Ölçüm Yönetimi ve Uyumun Önündeki Engeller

Amaç: Bu çalışma bazal-bolus insülin tedavisi kullanan tip 2 diyabetlilerin kan şekeri ölçüm yönetimi ve uyum sağlamalarının önündeki engelleri belirlemek amacıyla yapılmıştır. Bireyler ve Yöntem: Çalışmaya HbA1c değeri >=%7.5 olan, en az 1 yıldır insülin kullanan, çalışmaya katılmaya istekli 23 tip 2 diyabetli dahil edilmiştir. Yarı yapılandırılmış görüşme formu ile 35-40 dk süren derinlemesine görüşme yapılmıştır. Elde edilen veriler Collaizzi'nin veri analiz yöntemine göre değerlendirilmiştir. Bulgular: Hastaların %56.5'i erkek, %73.9'u evli olup yaş ortalaması 61±6 yıl, hastalık süresi 15±6 yıl ve HbA1c ortalaması %9.5±1.4'dür. Çalışmada 5 ana tema 9 alt tema belirlenmiştir. Temalar (1) yaşam biçimi ile ilgili sorunlar, (2) Diyabet ve kan glukoz düzeyini izlemek ile ilgili bilgi yetersizliği, (3) Motivasyon yetersizliği, (4) Sağlık ekibi ile paylaşımlar/sorunlar, (5) Ölçüm aletlerini yanlış kullanmadır. Sonuç: Çalışmada hastaların kan şekeri ölçümünü istenen şekilde yapmadıkları ve yaşam biçimi haline getiremedikleri görülmüştür

Barriers on Management and Compliance of Self-Monitoring of Blood Glucose in Type 2 Diabetes on Basal-Bolus Insulin Therapy

Aim: This study was conducted to determine the barriers on management and compliance of self- monitoring of blood glucose (SMBG) in type 2 diabetic individuals who take on basal-bolus insulin therapy. Subjects and Methods: Twenty-three type 2 diabetic patients (56.5% men, 73.9% married) whose HbA1c values were ≥7.5%, who had been using insulin for at least 1 year were included in the study. All the patients had a semistructured in-depth interview for 30-40 minutes. The obtained data were evaluated according to Colaizzi’s data analysis method. Results: While 56.5% of the patients were male and 73.9% were married, the mean age was 61 ± 6 years, the duration of illness was 15 ± 6 years and the mean HbA1c was 9.5 ± 1.4%. Five main themes and nine sub-themes were identified in the study. The themes were; (1) Problems about lifestyle, (2) Lack of information regarding diabetes and blood glucose monitoring, (3) Lack of motivation, (4) Sharing/problems with the healthcare team, (5) Not using the measurement tools correctly. Conclusion: Our study showed that patients did not perform SMBG regularly as desired and could not turn it into their lifestyle

PDF

___

1. Lebovitz HE. Treating hyperglycemia in type 2 diabetes: new goals and strategies. Cleve Clin J Med 2002;69(10):809-820.
2. Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002; 347(17):1342-1349.
3. Wright A, Burden AC, Paisey RB, Cull CA, Holman RR. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25(2):330-336.
4. American Diabetes Association. Standards of medical care in diabetes-2017. Diabetes Care 2017;40(Suppl.1):48-56.
5. DCCT (The Diabetes Control and Complications Trial Research Group). The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:997-986.
6. United Kingdom Prospective Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or compared with conventional treatment and risk of complications in patients wity type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
7. Welschen LMC, Bloemendal E, Nijpels G, Dekker JM, Heine PJ, Stalman VAB, et al. Self monitoring of blood glucose with type 2 diabetes who are not using insulin a systematic review. Diabetes Care 2005;28(6):1510- 1517.
8. Martin S, Schneider B, Lodwing V, Kurth HJ, Kolb H, Scherbaum WA. Self monitoring of blood glucose in type 2 diabetes and long-term outcome: An epidemiological cohort study. Diabetologia 2006;49(2):271-278
9. TEMD Diabetes Mellitus Çalışma Grub. TEMD Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu, Hasta Eğitim Broşürleri Serisi, Miki Matbaacılık, Ankara, 2016, s.15-24.
10. Berlin I, Bisserbe JC, Eiber R, Balsa N, Sachon C, Bosquet F, et al. Phobic symptoms, particulary the fear of blood and injury, are associated with poor glycemic control in type 1 diabetic adults. Diabetes Care 1997;20(2):176-178.
11. Evans JMM, Nevton RW, Ruta DA, MacDonald TM, Stevenson RJ, Morris AD. Frequency of blood glucose monitoring in relation to glycemic control: observational study with diabetes database. BMJ 1999;319(7202):83- 86.
12. Bergenstal RM, Gavin JR. Global Consensus Conference on GlucoseMonitoring Panel: The role of self-monitoring of blood glucose in the care of patients with diabetes: report of a global consensus conference. Am J Med 2005;118(Suppl 9A):1-6.
13. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self monitoring of blood glucose among persons with diabetes. Diabetes Educ 2004;30(1):112- 125.
14. Davidson J. Strategies for improving glycemic control: effective use ofglucose monitoring. Am J Med 2005;118(Suppl 9A):27-32.
15. Mollema ED, Snoek FJ, Pouwer F, Heine RJ, van der Ploeg HM. Diabetes fear of injecting and self-testing questionnaire. A psychometric evaluation. Diabetes Care 2000;23(6):765-769.
16. Fisher WA, Kohut T, Schachner H, Stenger P. Understanding self monitoring of blood glucose among individuals with type 1 and type 2 diabetes. An information-motivation-behavioral skills analysis. Diabetes Educ 2011;37:85-94.
17. Snoek FJ. Breaking the barriers to optimal glycaemic control: what physicians need to know from patients’ perspectives. Int J Clin Prac Suppl 2002;129:80-84.
18. Hortensius J, Kars MC, Wierenga WS, Kleefstra N, Bilo HJG, Bijl JJ. Perspectives of patients with type 1 or insulintreated type 2 diabetes on self-monitoring of blood glucose: a qualitative study BMC Public Health 2012;12:167.
19. Colaizzi P. Psychological research as the phenomenologist views it. In: Valle RS, King M, editors. Existential phenomenological alternatives for psychology. New York: Oxford University Press; 1978. 20. Evan B. Self monitoring of blood glucose: The basics. Clinic Diab 2002;20(1):45-47.
21. Boyle PJ, Zrebiec J. Physiology and behavioral aspects of glycemic control and hypoglycemia in diabetes. Sout Med J 2007;100(2):175-182.
22. Nakar S, Yitzhaki G, Rosenberg R, Vinker S. Transition to insulin in Type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriers. J Diabetes Complications 2007;21(4):220-226.
23. Metsch J, Tillil H, Köbberling J, Sartory G. On the relation among psychological distress, diabetes-related health behavior, and level of glycosylated hemoglobin in type 1 diabetes. Int J Behav Med 1995;2(2):104-117.
24. Berlin I, Bisserbe JC, Eiber R, Balsa N, Sachon C, Bosquet F, et al. Phobic symptoms, particulary the fear of blood and injury, are associated with poor glycemic control in type 1 diabetic adults. Diabetes Care 1997;20(2):176-178.